Reaction Process: Reactome:R-HSA-5218859
Regulated Necrosis related metabolites
find 2 related metabolites which is associated with chemical reaction(pathway) Regulated Necrosis
RIP3 + UDP-GlcNAc ⟶ OGlcNAc-T467-RIP3 + UDP
disulfiram
P - Antiparasitic products, insecticides and repellents > P03 - Ectoparasiticides, incl. scabicides, insecticides and repellents > P03A - Ectoparasiticides, incl. scabicides > P03AA - Sulfur containing products N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BB - Drugs used in alcohol dependence C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2160 - Proteasome Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D065086 - Acetaldehyde Dehydrogenase Inhibitors D002491 - Central Nervous System Agents > D000427 - Alcohol Deterrents C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C1744 - Multidrug Resistance Modulator C471 - Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Disulfiram (Tetraethylthiuram disulfide) is a specific inhibitor of?aldehyde-dehydrogenase (ALDH1), used for the treatment of chronic alcoholism by producing an acute sensitivity to alcohol. Disulfiram inhibits gasdermin D (GSDMD) pore formation in liposomes and inflammasome-mediated pyroptosis and IL-1β secretion in human and mouse cells. Disulfiram, a copper ion carrier,?with?Cu2+ increases intracellular ROS levels and induces cuproptosis[1][2][3][4][5][6].
Diethyldithiocarbamic acid
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D064449 - Sequestering Agents > D002614 - Chelating Agents C308 - Immunotherapeutic Agent > C2139 - Immunostimulant D007155 - Immunologic Factors